Apr 10, 2023
Daniel Goldman- Amount
- $15,001 to $50,000
- Filed
- May 19, 2023
Congress ticker disclosure profile
As of August 1 at 11:20 PM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference ROKU. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
41
Member filers
8
Disclosed ranges
$177K
Most active member desks
21 sells vs 19 buys
Democrat · House · RI-2.0
Republican · Senate · KS
Democrat · House · CA-31.0
Democrat · House · CA-17.0
Republican · House · TX-10.0
Democrat · House · NJ-5.0
Democrat · House · NY-10.0
Republican · Senate · GA
Latest trade Apr 10, 2023
Apr 10, 2023
Daniel GoldmanJan 11, 2023
Ro KhannaJun 27, 2022
Ro KhannaMay 23, 2022
Ro KhannaMay 5, 2022
Ro KhannaFeb 10, 2022
James R. LangevinNov 2, 2021
Ro KhannaMay 7, 2021
James R. LangevinMay 6, 2021
James R. LangevinApr 16, 2021
Josh GottheimerApr 6, 2021
James R. LangevinApr 6, 2021
James R. LangevinMar 26, 2021
James R. LangevinMar 24, 2021
James R. LangevinMar 15, 2021
Josh GottheimerDec 11, 2020
Gilbert CisnerosNov 10, 2020
Gilbert CisnerosOct 9, 2020
Gilbert CisnerosSep 15, 2020
Roger W. MarshallSep 15, 2020
Roger W. MarshallSep 4, 2020
Roger W. MarshallSep 4, 2020
Roger W. MarshallJul 8, 2020
Roger MarshallMay 19, 2020
Roger W. MarshallMay 19, 2020
Roger W. MarshallApr 20, 2020
James R. LangevinFeb 21, 2020
James R. LangevinFeb 18, 2020
James R. LangevinFeb 10, 2020
James R. LangevinFeb 7, 2020
Kelly LoefflerJan 29, 2020
Gilbert CisnerosJan 27, 2020
James R. LangevinJan 24, 2020
James R. LangevinDec 30, 2019
Gilbert CisnerosSep 16, 2019
Gilbert CisnerosSep 28, 2017
Roger W. MarshallSep 28, 2017
Roger W. MarshallDec 14, 2015
Michael T. McCaulDec 10, 2015
Michael T. McCaulDec 9, 2015
Michael T. McCaulDec 8, 2015
Michael T. McCaul| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Apr 10, 2023 | Daniel Goldman | Buy | $15,001 to $50,000 | May 19, 2023 | Open card |
| Jan 11, 2023 | Ro Khanna | Sell | Receipt pending ingestion | Feb 7, 2023 | Open card |
| Jun 27, 2022 | Ro Khanna | Buy | Receipt pending ingestion | Jul 7, 2022 | Open card |
| May 23, 2022 | Ro Khanna | Sell | Receipt pending ingestion | Jun 10, 2022 | Open card |
| May 5, 2022 | Ro Khanna | Buy | Receipt pending ingestion | Jun 10, 2022 | Open card |
| Feb 10, 2022 | James R. Langevin | Buy | $1,001 to $15,000 | Mar 4, 2022 | Open card |
| Nov 2, 2021 | Ro Khanna | Exchange | Receipt pending ingestion | Dec 7, 2021 | Open card |
| May 7, 2021 | James R. Langevin | Sell | $1,001 to $15,000 | Jun 10, 2021 | Open card |
| May 6, 2021 | James R. Langevin | Buy | $1,001 to $15,000 | Jun 10, 2021 | Open card |
| Apr 16, 2021 | Josh Gottheimer | Sell | $1,001 to $15,000 | May 7, 2021 | Open card |
| Apr 6, 2021 | James R. Langevin | Sell | $1,001 to $15,000 | May 13, 2021 | Open card |
| Apr 6, 2021 | James R. Langevin | Sell | $15,001 to $50,000 | May 13, 2021 | Open card |
| Mar 26, 2021 | James R. Langevin | Buy | $1,001 to $15,000 | Apr 9, 2021 | Open card |
| Mar 24, 2021 | James R. Langevin | Buy | $1,001 to $15,000 | Apr 9, 2021 | Open card |
| Mar 15, 2021 | Josh Gottheimer | Buy | $1,001 to $15,000 | Apr 21, 2021 | Open card |
| Dec 11, 2020 | Gilbert Cisneros | Sell | $1,001 to $15,000 | Jan 11, 2021 | Open card |
| Nov 10, 2020 | Gilbert Cisneros | Sell | $1,001 to $15,000 | Dec 15, 2020 | Open card |
| Oct 9, 2020 | Gilbert Cisneros | Sell | $1,001 to $15,000 | Nov 5, 2020 | Open card |
| Sep 15, 2020 | Roger W. Marshall | Sell | Receipt pending ingestion | Oct 13, 2020 | Receipt pending ingestion |
| Sep 15, 2020 | Roger W. Marshall | Sell | $1,001 to $15,000 | Oct 13, 2020 | Open card |
| Sep 4, 2020 | Roger W. Marshall | Buy | Receipt pending ingestion | Oct 13, 2020 | Receipt pending ingestion |
| Sep 4, 2020 | Roger W. Marshall | Buy | $1,001 to $15,000 | Oct 13, 2020 | Open card |
| Jul 8, 2020 | Roger Marshall | Sell | Receipt pending ingestion | Sep 28, 2021 | Receipt pending ingestion |
| May 19, 2020 | Roger W. Marshall | Buy | Receipt pending ingestion | Jun 3, 2020 | Receipt pending ingestion |
| May 19, 2020 | Roger W. Marshall | Buy | $1,001 to $15,000 | Jun 3, 2020 | Open card |
| Apr 20, 2020 | James R. Langevin | Sell | Receipt pending ingestion | May 5, 2020 | Receipt pending ingestion |
| Feb 21, 2020 | James R. Langevin | Buy | Receipt pending ingestion | Mar 30, 2020 | Open card |
| Feb 18, 2020 | James R. Langevin | Buy | Receipt pending ingestion | Mar 3, 2020 | Open card |
| Feb 10, 2020 | James R. Langevin | Sell | Receipt pending ingestion | Mar 3, 2020 | Open card |
| Feb 7, 2020 | Kelly Loeffler | Sell | Receipt pending ingestion | Mar 12, 2020 | Receipt pending ingestion |
| Jan 29, 2020 | Gilbert Cisneros | Buy | Receipt pending ingestion | Feb 18, 2020 | Open card |
| Jan 27, 2020 | James R. Langevin | Buy | Receipt pending ingestion | Mar 3, 2020 | Open card |
| Jan 24, 2020 | James R. Langevin | Buy | Receipt pending ingestion | Mar 3, 2020 | Open card |
| Dec 30, 2019 | Gilbert Cisneros | Sell | Receipt pending ingestion | Jan 10, 2020 | Open card |
| Sep 16, 2019 | Gilbert Cisneros | Buy | Receipt pending ingestion | Oct 16, 2019 | Open card |
| Sep 28, 2017 | Roger W. Marshall | Sell | Receipt pending ingestion | Aug 6, 2018 | Receipt pending ingestion |
| Sep 28, 2017 | Roger W. Marshall | Buy | Receipt pending ingestion | Aug 6, 2018 | Receipt pending ingestion |
| Dec 14, 2015 | Michael T. McCaul | Sell | Receipt pending ingestion | Feb 3, 2016 | Open card |
| Dec 10, 2015 | Michael T. McCaul | Sell | Receipt pending ingestion | Feb 3, 2016 | Open card |
| Dec 9, 2015 | Michael T. McCaul | Sell | Receipt pending ingestion | Feb 3, 2016 | Open card |
| Dec 8, 2015 | Michael T. McCaul | Sell | Receipt pending ingestion | Feb 3, 2016 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 16 of 41 filed rows include disclosed amount ranges (39%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.